SCHEMBL5541780

SCHEMBL5541780

O=C(OCc1ccccc1N1C(=O)c2ccccc2C1=O)c1ccccc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.51
NR1H3 Q13133 4/20 0.48
NR1H2 P55055 2/20 0.46
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
RAB9A P51151 3/20 0.42
NPC1 O15118 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 1/20 0.41
CASP3 P42574 1/20 0.40
SENP8 Q96LD8 1/20 0.40
SENP7 Q9BQF6 1/20 0.40
SENP6 Q9GZR1 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
ATM Q13315 1/20 0.40
LMNA P02545 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5539344 0.85 NR1H3 (0.47) TDP1NR1H3NR1H2MEN1KMT2A
SCHEMBL10085968 0.80 NR1H3 (0.43) TDP1NR1H3NR1H2MEN1KMT2A
SCHEMBL5538981 0.79 TDP1 (0.62) TDP1NR1H3MEN1KMT2A
SCHEMBL94305 0.78 TDP1 (0.69) TDP1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL1903362 0.77 TDP1 (0.67) TDP1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL27396363 0.77 TDP1 (0.67) TDP1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL29802762 0.77 TDP1 (0.67) TDP1KMT2ARAB9ANPC1L3MBTL1
Hydrochloric Acid SCHEMBL28161933 0.77 TDP1 (0.67) TDP1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5069698 0.77 TDP1 (0.67) TDP1KMT2ARAB9ANPC1L3MBTL1
SCHEMBL5535974 0.76 TDP1 (0.58) TDP1NR1H3NR1H2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120115817-A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES EMS S.A. (BR) 2012-05-10 US disclosed
US-20120115817-A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES EMS S.A. (BR) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120115817-A1 PHTHALIMIDE DERIVATIVES OF NON-STEROIDAL ANTI-INFLAMMATORY COMPOUNDS AND/OR TNF-ALPHA MODULATORS, METHOD FOR PRODUCING SAME, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND USES THEREOF FOR THE TREATMENT OF INFLAMMATORY DISEASES TNF, PER2, CRY1 TDP1 4039/4885NR1H3 585/4885NR1H2 398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.